Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03301012 · ClinicalTrials.gov registry record · NA
Smartphone Addiction Recovery Coach for Young Adults (SARC-YA) Experiment
A NA study, sponsored by Chestnut Health Systems.
- Completed
- Registry status
- NA
- Development phase
- 237
- Enrollment target
NCT03301012 is a NA study that has completed, run by Chestnut Health Systems. The registered enrollment target is 237 participants.
The verdict
NCT03301012, a NA study, has completed, sponsored by Chestnut Health Systems.
- COMPLETED
- Registry status
- NA
- Development phase
- 237 participants
- Enrollment target
Study Summary
At discharge from outpatient treatment, researchers will recruit 300 young adults and randomly assign them to recovery support as usual control condition or the Smartphone Addiction Recovery Coach for Young Adults (SARC-YA) experimental condition. Participants in the experimental conditions will receive a smartphone, a calling/texting/data plan, and the SARC-YA mobile applications for the first 6 months post treatment discharge. Experimental participants will 1) complete a 2-3 minute recovery-focused ecological momentary assessment (EMA) at 5 random times a day, receive feedback on their current answers, and provided access to behavioral charting of their past answers over time; and 2) receive continuous access to a suite of self-initiated ecological momentary interventions (EMI) to support their recovery via tool box of coping tools, apps related to getting support, and apps related to maintaining a healthy lifestyle. Data include standardized assessments, urine tests, mobile phone metadata, EMA responses, and EMI utilization. The study's primary aim and hypothesis are: Aim 1: Test the effects of experimental assignment on the frequency of substance use. H1 Relative to the control group, participants in the experimental group will have lower scores on the quarterly Substance Frequency Scale (3, 6, 9 months post- discharge).
Interventions
- OTHER Recovery support as usual
- OTHER Smartphone assisted relapse prevention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 237 participants |
| Start Date | 2020-10-30 |
| Est. Completion | 2024-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03301012
The ClinicalTrials.gov registry entry for NCT03301012 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 237 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Chestnut Health Systems, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Recovery support as usual is the first listed.
NCT03301012 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03301012 about?
NCT03301012 is a clinical study titled "Smartphone Addiction Recovery Coach for Young Adults (SARC-YA) Experiment". At discharge from outpatient treatment, researchers will recruit 300 young adults and randomly assign them to recovery support as usual control condition or the Smartphone Addiction Recovery Coach for Young Adults (SARC-YA) experimental condition. Participants in the experimental conditions will rec...
What is the current status of trial NCT03301012?
This trial is currently completed. It is a NA study. The enrollment target is 237 participants. The study started on 2020-10-30. Estimated completion is 2024-05-31.
What interventions are being tested in trial NCT03301012?
The interventions under investigation include: Recovery support as usual (OTHER), Smartphone assisted relapse prevention (OTHER).
Who is sponsoring clinical trial NCT03301012?
This trial is sponsored by Chestnut Health Systems, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.